US Stock MarketDetailed Quotes

NOVNQ NVN LIQUIDATION INC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Apr 30 16:00 ET
28.02Market Cap0.00P/E (TTM)

About NVN LIQUIDATION INC Company

NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Company Profile

SymbolNOVNQ
Company NameNVN LIQUIDATION INC
CEOMs. Paula Brown Stafford
MarketPink Market
Employees90
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Paula Brown Stafford
  • Chairman of the Board, President and Chief Executive Officer
  • --
  • John M. Gay
  • Chief Financial Officer, Chief Accounting Officer and Secretary
  • 568.23K
  • John A. Donofrio, Jr
  • Executive Vice President and Chief Operating Officer
  • 749.93K
  • Brian M. Johnson
  • Chief Commercial Officer
  • --
  • Andrew J. Novak
  • Vice President, Accounting and Business Operations
  • --
  • Steven D. Skolsky
  • Independent Director
  • 162.19K
  • Robert J. Keegan
  • Independent Director
  • 182.81K
  • Machelle Sanders
  • Independent Director
  • 163.13K
  • W. Kent Geer
  • Lead Independent Director
  • 202.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data